These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 593728)

  • 21. Temporal differences in praziquantel- and oxamniquine-induced tegumental damage to adult Schistosoma mansoni: implications for drug-antibody synergy.
    Fallon PG; Fookes RE; Wharton GA
    Parasitology; 1996 Jan; 112 ( Pt 1)():47-58. PubMed ID: 8587801
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Action of oxamniquine on Schistosoma mansoni in mice experimentally infected with a strain from Kenya].
    Kohn A; Bruce J; Kinoti G; Mutahi WT; Coles G; Katz N
    Mem Inst Oswaldo Cruz; 1987; 82 Suppl 4():361. PubMed ID: 3151113
    [No Abstract]   [Full Text] [Related]  

  • 23. Oxamniquine in the prevention of bilharzial infection.
    Jewsbury JM
    Cent Afr J Med; 1977 Nov; 23(11 Suppl):18-20. PubMed ID: 606372
    [No Abstract]   [Full Text] [Related]  

  • 24. Oxamniquine resistance in Schistosoma mansoni: fact or fiction?
    Yeang FS; Marshall I; Huggins M
    Ann Trop Med Parasitol; 1987 Jun; 81(3):337-9. PubMed ID: 3662676
    [No Abstract]   [Full Text] [Related]  

  • 25. Inhibitory effect of oxamniquine on the detachment of the tail of Schistosoma mansoni.
    Melo AL; Pereira LH
    J Parasitol; 1980 Dec; 66(6):1067-8. PubMed ID: 7218106
    [No Abstract]   [Full Text] [Related]  

  • 26. Drug-resistant schistosomiasis: resistance to praziquantel and oxamniquine induced in Schistosoma mansoni in mice is drug specific.
    Fallon PG; Doenhoff MJ
    Am J Trop Med Hyg; 1994 Jul; 51(1):83-8. PubMed ID: 8059919
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo cercaria-schistosomulum transformation: inhibitory effect of oxamniquine.
    Melo AL; Pereira LH; Corrêa CR
    Trans R Soc Trop Med Hyg; 1978; 72(2):158-9. PubMed ID: 653787
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The significance of variation in the susceptibility of Schistosoma mansoni to the antischistosomal drug oxamniquine.
    Kinoti GK
    Mem Inst Oswaldo Cruz; 1987; 82 Suppl 4():151-6. PubMed ID: 3509180
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of oxamniquine on Schistosoma mansoni in experimentally infected mice].
    Kohn A; Serapiao CJ; Katz N; Dias EP
    Rev Inst Med Trop Sao Paulo; 1979; 21(5):217-27. PubMed ID: 549207
    [No Abstract]   [Full Text] [Related]  

  • 30. Efficacy of treatment of murine Schistosoma mansoni infections with praziquantel and oxamniquine correlates with infection intensity: role of host antibody.
    Fallon PG; Hamilton JV; Doenhoff MJ
    Parasitology; 1995 Jul; 111 ( Pt 1)():59-66. PubMed ID: 7609991
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Schistosoma mansoni: evaluation of the activity of oxamniquine on schistosomules, at 24 hours after infection.
    Coelho PM; de Mello RT; Gerken SE
    Rev Inst Med Trop Sao Paulo; 1993; 35(6):557-61. PubMed ID: 7997761
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Why does oxamniquine kill Schistosoma mansoni and not S. haematobium and S. japonicum?
    Rugel AR; Guzman MA; Taylor AB; Chevalier FD; Tarpley RS; McHardy SF; Cao X; Holloway SP; Anderson TJC; Hart PJ; LoVerde PT
    Int J Parasitol Drugs Drug Resist; 2020 Aug; 13():8-15. PubMed ID: 32315953
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Resistance of schistosomes to hycanthone and oxamniquine.
    Cioli D; Pica-Mattoccia L; Archer S
    Mem Inst Oswaldo Cruz; 1989 Oct; 84 Suppl 1():38-45. PubMed ID: 2638729
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oxamniquine in the treatment of various schistosome infections in South Africa.
    Pitchford RJ; Lewis M
    S Afr Med J; 1978 Apr; 53(17):677-80. PubMed ID: 354047
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of Schistosoma mansoni infection with oxamniquine in Riyadh, Saudi Arabia.
    Al-Aska AK
    Trop Med Parasitol; 1985 Dec; 36(4):213-4. PubMed ID: 3937212
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Observations on the treatment of mansoni schistosomiasis with oxamniquine.
    Pedro RD; Dias LC; Amato Neto V; De Carvalho SA
    Rev Bras Pesqui Med Biol; 1979 Jun; 12(2-3):207-11. PubMed ID: 515473
    [No Abstract]   [Full Text] [Related]  

  • 37. The treatment of schistosomiasis mansoni in Murang'a District, Kenya: a double blind controlled trial of three hycanthone regimens and oxamniquine.
    Rees PH; Bowry HN; Roberts JM; Thuku JJ
    Am J Trop Med Hyg; 1975 Sep; 24(5):823-6. PubMed ID: 1190368
    [No Abstract]   [Full Text] [Related]  

  • 38. Sensibility of different larval stages of Schistosoma mansoni to the larvae disappearing reaction (LDR) in murine schistosomiasis (1).
    de Melo AL; Pereira LH; Chamone M
    Rev Inst Med Trop Sao Paulo; 1986; 28(6):395-9. PubMed ID: 3110909
    [No Abstract]   [Full Text] [Related]  

  • 39. Use of praziquantel in patients with schistosomiasis mansoni previously treated with oxamniquine and/or hycanthone: resistance of Schistosoma mansoni to schistosomicidal agents.
    de Souza Dias LC; de Jesus Pedro R; Deberaldini ER
    Trans R Soc Trop Med Hyg; 1982; 76(5):652-9. PubMed ID: 7179419
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Migration and fate of Schistosoma mansoni in mice treated with oxaminiquine.
    Oliveira MA; Pellegrino J; Pereira LH; Valadares TE
    Rev Inst Med Trop Sao Paulo; 1976; 18(5):298-300. PubMed ID: 1006062
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.